SecBot SecBot
SECBOTREPLAY Home › Report › DAWN

DAWN · Day One Biopharmaceuticals (DAWN) was acquired by Servier…

Day One Biopharmaceuticals, Inc. · 8-K filed Apr 23, 2026 at 08:54 ET

At the news

NEUTRALIMPACT 9/10

8-K filed Apr 23, 2026 at 08:54 ET

Day One Biopharmaceuticals (DAWN) was acquired by Servier Pharmaceuticals in an all-cash transaction valued at $2.5 billion, resulting in delisting from Nasdaq and termination of all existing equity plans. The merger closed after Servier secured 85.34% of shares in a tender offer.

  • Servier Pharmaceuticals completed acquisition of Day One Biopharmaceuticals for $2.5 billion in equity value
  • All outstanding shares converted to $21.50 in cash per share
  • Company delisted from Nasdaq following merger completion
  • Board and officers replaced with Servier appointees

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access